IP Library Patent Application 13995912
Patent Application
App. No. 13/995,912

MODIFIED PHOTOSYNTHETIC MICROORGANISMS FOR PRODUCING LIPIDS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/995,912
Abstract

This disclosure describes genetically modified photosynthetic microorganisms, e.g., Cyanobacteria, that overexpress an acyl-acyl carrier protein reductase (acyl-ACP reductase). These microorganisms may optionally overexpress one or more fatty acid synthesis proteins such as ACP and ACCase, and/or one or more polypeptides associated with glycogen breakdown. Also included are photosynthetic microorganisms comprising mutations or deletions in a glycogen biosynthesis or storage pathway, which accumulate a reduced amount of glycogen under reduced nitrogen conditions as compared to a wild type photosynthetic microorganism. The modified photosynthetic microorganisms provided herein are capable of producing increased amounts of lipids such as fatty acids or wax esters and/or synthesizing triglycerides.

Claims (53)

1 .- 119 . (canceled)

120 . A modified Cyanobacterium, comprising an overexpressed acyl-acyl carrier protein (ACP) reductase polypeptide,

wherein said modified Cyanobacterium produces an increased amount of lipid as compared to a wild-type Cyanobacterium.

121 . The modified Cyanobacterium microorganism of claim 120 , further comprising one or more of the following:

(i) an overexpressed aldehyde dehydrogenase;

(ii) reduced expression of one or more genes of a glycogen biosynthesis or storage pathway as compared to a wild-type Cyanobacterium;

(iii) one or more introduced polynucleotides encoding a protein of a glycogen breakdown pathway;

(iv) reduced expression of one or more genes encoding an endogenous aldehyde decarbonylase;

(v) reduced expression of one or more genes encoding an acyl-ACP synthetase (Aas);

(vi) an overexpressed acyl carrier protein (ACP);

(vii) an overexpressed acetyl coenzyme A carboxylase (ACCase); or

(viii) any combination of (i)-(vii).

122 . The modified Cyanobacterium of claim 121 , wherein said overexpressed acyl-ACP reductase polypeptide, said overexpressed aldehyde dehydrogenase, or both is/are encoded by (i) an endogenous polynucleotide which is operably linked to one or more introduced regulatory elements, or (ii) an introduced polynucleotide.

123 . The modified Cyanobacterium of claim 120 , further comprising an overexpressed alcohol dehydrogenase in combination with an overexpressed DGAT having wax ester synthase activity and one or more of the following:

(i) reduced expression of one or more genes of a glycogen biosynthesis or storage pathway as compared to a wild-type Cyanobacterium;

(ii) one or more introduced polynucleotides encoding a protein of a glycogen breakdown pathway;

(iii) reduced expression of one or more genes encoding an endogenous aldehyde decarbonylase;

(iv) reduced expression of one or more genes encoding an acyl-ACP synthetase (Aas);

(v) an overexpressed acyl carrier protein (ACP);

(vi) an overexpressed acetyl coenzyme A carboxylase (ACCase);

(vii) reduced expression of an endogenous aldehyde dehydrogenase; or

(viii) any combination of (i)-(vii),

wherein said Cyanobacterium produces an increased amount of wax ester(s) as compared to a wild-type Cyanobacterium or unmodified Cyanobacterium of the same species.

124 . The modified Cyanobacterium of claim 120 , wherein said lipid is a free fatty acid (FFA), triglyceride or wax ester.

125 . The modified Cyanobacterium of claim 120 , wherein said modified Cyanobacterium is a Synechococcus elongatus PCC 7942; a salt tolerant variant of Synechococcus elongatus sp. PCC 7942; a Synechococcus elongatus sp. PCC 7002; or a Synechocystis elongatus sp. PCC 6803.

126 . A method of producing a modified Cyanobacterium that produces or accumulates an increased amount of lipid as compared to a corresponding wild-type Cyanobacterium, comprising overexpressing an acyl-acyl carrier protein (ACP) reductase polypeptide in said modified Cyanobacterium.

127 . The method of claim 126 , wherein said lipid is a free fatty acid (FFA), triglyceride or wax ester.

128 . The method of claim 126 , further comprising one or more of the following:

(i) overexpressing an aldehyde dehydrogenase;

(ii) underexpressing one or more genes of a glycogen biosynthesis or storage pathway as compared to a wild-type Cyanobacterium;

(iii) introducing one or more polynucleotides encoding a protein of a glycogen breakdown pathway;

(iv) underexpressing one or more genes encoding an endogenous aldehyde decarbonylase;

(v) underexpressing one or more genes encoding an acyl-ACP synthetase (Aas);

(vi) overexpressing an acyl carrier protein (ACP);

(vii) overexpressing an acetyl coenzyme A carboxylase (ACCase); or

(viii) any combination of (i)-(vii).

129 . The method of claim 128 , comprising (i) introducing one or more regulatory elements which are operably linked to an endogenous polynucleotide that encodes said acyl-ACP reductase, said aldehyde dehydrogenase, or both, and/or (ii) introducing a polynucleotide that encodes said acyl-ACP reductase, said aldehyde dehydrogenase, or both.

130 . The method of claim 126 , further comprising overexpressing an alcohol dehydrogenase in combination with an overexpressed DGAT having wax ester synthase activity and one or more of the following:

(i) underexpressing one or more genes of a glycogen biosynthesis or storage pathway as compared to a wild-type Cyanobacterium;

(ii) introducing one or more introduced polynucleotides encoding a protein of a glycogen breakdown pathway;

(iii) underexpressing one or more genes encoding an endogenous aldehyde decarbonylase;

(iv) underexpressing one or more genes encoding an acyl-ACP synthetase (Aas);

(v) overexpressing an acyl carrier protein (ACP);

(vi) overexpressing an acetyl coenzyme A carboxylase (ACCase);

(vii) underexpressing an endogenous aldehyde dehydrogenase; or

(viii) any combination of (i)-(vii),

wherein said Cyanobacterium produces an increased amount of wax ester(s) as compared to a wild-type Cyanobacterium or unmodified Cyanobacterium of the same species.

131 . The method of claim 126 , wherein said modified Cyanobacterium is a Synechococcus elongatus PCC 7942; a salt tolerant variant of Synechococcus elongatus sp. PCC 7942; a Synechococcus elongatus sp. PCC 7002; or a Synechocystis elongatus sp. PCC 6803.

132 . A method for the production of lipids, comprising culturing a modified Cyanobacterium according to claim 120 .

133 . The method of claim 132 , wherein said lipid is a free fatty acid, triglyceride or wax ester.

134 . A method for the production of lipids comprising:

preparing a modified Cyanobacterium which overexpresses acyl-acyl carrier protein (ACP) reductase; and

culturing said modified Cyanobacterium to produce lipids.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2013
From: ROBERTS, JAMES; CROSS, FRED; KAISER, BRETT K.
To: MATRIX GENETICS, LLC
Reel/Frame 030884/0245 →